The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Concentration‐QT Relationships Play a Key Role in the Evaluation of Proarrhythmic Risk During Regulatory Review
Abstract
The criterion for assessing whether a drug prolongs QT as described in the International Conference on Harmonization topic E14 guideline does not explicitly account for individual drug concentrations. The authors’ experience with reviewing QT studies indicates that understanding the relationship, if any, between individual drug concentration and QT change provides important additional information to support regulatory decision making. Therefore, regulatory reviews of “thorough QT” studies routinely include a characterization of the concentration‐QT relationship. The authors provide examples to illustrate how the concentration‐QT relationship has been used to plan and interpret the thorough QT study, to evaluate QT risk for drugs that have no thorough QT studies, to assess QT risk in subpopulations, to make dose adjustments, and to write informative drug labels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Terfenadine-Ketoconazole Interaction: Pharmacokinetic and Electrocardiographic Consequences
Honig, P. K. (1993) · JAMA · doi:10.1001/jama.1993.03500120051025 · Cited by 664
Cited by
Johannesen, L., Vicente, J., Mason, J. W., Sanabria, C., Waite-Labott, K., Hong, M., Guo, P., Lin, J., Sørensen, J. S., Galeotti, L., et al. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.155 · Cited by 254
Self-citationModel‐Informed Drug Development: Current US Regulatory Practice and Future Considerations
Wang, Y., Zhu, H., Madabushi, R., Liu, Q., Huang, S., & Zineh, I. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1363 · Cited by 228
Self-citationDetection of QTc effects in small studies—Implications for replacing the thorough QT study
Ferber, G., Zhou, M., & Darpo, B. (2015) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12227 · Cited by 59
Metadata
- Authors
- Garnett, C. E., Beasley, N., Bhattaram, V. A., Jadhav, P. R., Madabushi, R., Stockbridge, N., Tornøe, C. W., Wang, Y., Zhu, H., & Gobburu, J. V.
- Venue
- The Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2008-01
- Volume
- 48
- Issue
- 1
- Pages
- 13-18
- ISSN
- 0021-9754 (ISSN-L)
- 0091-2700
- 1552-4604
- OpenAlex
- W2096104621
- Cited by
- 219
- References
- 1
- FWCI
- 10.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Concentration‐QT Relationships Play a Key Role in the Evaluation of Proarrhythmic Risk During Regulatory Review. https://app.cochat.ai/papers/10.1177/0091270007307881
- The paper
- Garnett, C. E., Beasley, N., Bhattaram, V. A., Jadhav, P. R., Madabushi, R., Stockbridge, N., Tornøe, C. W., Wang, Y., Zhu, H., & Gobburu, J. V. (2008). Concentration‐QT Relationships Play a Key Role in the Evaluation of Proarrhythmic Risk During Regulatory Review. The Journal of Clinical Pharmacology. https://doi.org/10.1177/0091270007307881
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.